Wesana X Psytech

Wesana Health to Acquire Psytech in All Stock Deal

Recently public life sciences company, Wesana Health (WESA), is set to acquire Psytech Inc. for $21 million CAD in Wesana Health stock. Announcing the news today, Wesana said that Psytech will help contribute to its research of using psilocybin therapy to treat Traumatic Brain Injury (TBI).  Psytech’s current business model includes Tovana Solutions, a clinical […]

wesana health

As a Public Company, Wesana Health Aims to Solve Traumatic Brain Injury

Wesana Health (WESA), a life sciences company championing psilocybin therapy for traumatic brain injury (TBI), has gone public, commencing trading on the Canadian Stock Exchange (CSE) last month. The company has also announced a partnership with the World Boxing Council (WBC), in an effort to further promote its psychedelic therapies.  Wesana was founded by Chad […]

GH Research IPO

GH Research Files to Go Public Only Two Months After Raising $125 Million

The psychedelics space continues to see rapid growth, as a relatively quiet company, GH Research, filed to go public on June 4, 2021. This comes only two months after raising a nine-figure, oversubscribed series B round from RA Capital, RTW Investments, BVF Partners.  The Dublin-based biotech is focused on developing a novel and proprietary inhalable […]


Defiance ETFs Launches $PSY, the First U.S.-listed ETF Focused on Psychedelics

Yesterday, Psychedelic Invest published a post highlighting Defiance ETFs new psychedelic ETF and what it’s potential holdings may be. Today, we find out exactly what it contains as the fund is officially available to trade on the NYSE under the symbol $PSY. About Defiance: Founded in 2018, Defiance is a FinTech asset manager and an […]